Moderna’s leaders discussed the company’s COVID-19 vaccine at the J.P. Morgan Healthcare Conference, including whether doses can be halved in order to administer them to more people.
Moderna’s leaders discussed the company’s COVID-19 vaccine at the J.P. Morgan Healthcare Conference, including whether doses can be halved in order to administer them to more people.
Copyright © 2024 | WordPress Theme by MH Themes